A DAO effectively combines aspects of centralization and decentralization, is modular, and generally adopts characteristics from corporations and non-profits while remaining fundamentally distinct from both. Additionally neuroscience and mood disorders, have long struggled with data scaling, poor alignment of incentives, riskiness, and ultimately product innovation. Corporations have historically been divesting from neuropsychiatry and struggle with incentive alignments whereas non-profits and public spinouts struggle heavily with efficiency, human capital, and the ability to turn ideas into products. We believe Elata is a practical way to solve issues in neuropsychiatry for the following reasons: • A DAO is decentralized, open-source, and perhaps even more focused on genuine problem-solving, meaning anyone can contribute to and partake in upside of successful efforts permissionlessly. ‍ • Is able to cover the intense costs typically associated with biomedical R&D using funds from the DAO treasury. ‍ • Is scalable, modular (many initiatives can be executed simultaneously), and in turn, more efficient.